Akari Therapeutics PLC To Host a Virtual Key Opinion Leader Event Transcript
Good afternoon and welcome to the Akari Therapeutics KOL event. (Operator Instructions) As a reminder, this call is being recorded and a replay will be made available on the Akari website following the conclusion of the event.
I'd now like to turn the call over to Rachelle Jacques, President and Chief Executive Officer of Akari Therapeutics. Please go ahead, Rachelle.
Thanks, Tara, and welcome, everybody. As Tara mentioned, I'm Rachelle Jacques, CEO of Akari Therapeutics and really pleased to have you all here today. Thank you for joining our Key Opinion Leader event, and we're going to focus today on geographic atrophy and the potential of long-acting PASylated-nomacopan to address significant needs in the area.
So today's webinar is going to be featuring Dr. Elias Reichel. Of course, we are going to be making forward-looking statements. So just a take note there, please.
And let me now introduce Dr. Reichel, who is going to give us a brief overview of geographic
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
